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ABSTRACT
The neuromuscular activity of venom from Bothrops fonsecai, a lancehead endemic to southeastern Brazil, 
was investigated. Chick biventer cervicis (CBC) and mouse phrenic nerve-diaphragm (PND) preparations were 
used for myographic recordings and mouse diaphragm muscle was used for membrane resting potential (RP) 
and miniature end-plate potential (MEPP) recordings. Creatine kinase release and muscle damage were also 
assessed. In CBC, venom (40, 80 and 160mg/ml) produced concentration- and time-dependent neuromuscular 
blockade (50% blockade in 85±9 min and 73±8 min with 80 and 160mg/ml, respectively) and attenuated the 
contractures to 110mM ACh (78–100% inhibition) and 40mM KCl (45–90% inhibition). The venom-induced 
decrease in twitch-tension in curarized, directly-stimulated preparations was similar to that in indirectly stimu-
lated preparations. Venom (100 and 200mg/ml) also caused blockade in PND preparations (50% blockade in 
94±13 min and 49±8 min with 100 and 200mg/ml, respectively) but did not alter the RP or MEPP amplitude. In 
CBC, venom caused creatine kinase release and myonecrosis. The venom-induced decrease in twitch-tension 
and in the contractures to ACh and K+ were abolished by preincubating venom with commercial antivenom. 
These findings indicate that Bothrops fonsecai venom interferes with neuromuscular transmission essentially 
through postsynaptic muscle damage that affects responses to ACh and KCl. These actions are effectively pre-
vented by commercial antivenom.
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INTRODUCTION
Bothrops fonsecai is an uncommon terrestrial species of 
lancehead endemic to mountainous regions such as the Serra 
da Mantiqueira in the states of Minas Gerais, Rio de Janeiro 
and São Paulo in southeastern Brazil, where it is found in 
open areas and along the edges of forests dominated by 
Araucaria angustifolia pines at elevations of 1000–1800 m 
(Martins et al, 2002; Campbell and Lamar, 2004; Tashima 
et al, 2008). Taxonomically, Bothrops fonsecai is closely 
related to Bothrops alternatus, Bothrops cotiara and Both-
rops itapetiningae, that together form the alternatus species 
group (Salomão et al, 1997; Salomão et al, 1999; Martins 
et al, 2001; Wüster et al, 2002), all of which are stout-bod-
ied species (Martins et al, 2001). The diet of B. fonsecai is 
exclusively mammalian, as is that of B. alternatus and B. 
cotiara, whereas B. itapetiningae feeds predominantly on 
mammals (~43%) but also includes lizards (23%), anurans 
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(~21%), centipedes (9.5%) and birds (2.4%) (Martins et al, 
2002).
The limited geographic distribution of B. fonsecai and the 
difficulty in obtaining venom have resulted in few detailed 
studies of this species´ venom, with most investigations 
dealing with biochemical aspects. Rosenfeld et al (1959) 
reported that the coagulant activity of B. fonsecai venom 
was ~5 times greater than that of B. alternatus, B. cotiara 
and B. itapetiningae and ~60% greater than that of B. jara-
raca whereas its fibrinolytic activity was only 20% of the 
latter species. Subsequently, Nahas et al (1979) showed that 
this venom contained thrombin-like activity but was unable 
to produce prothrombin activator when preincubated with 
serum, factor V, and phospholipid. More recently, Queiroz 
et al (2008) reported that B. fonsecai venom contains PLA
2
, 
proteolytic and hyaluronidase activities that are neutral-
ized to varying degrees by commercial equine bothropic 
antivenom produced by the Butantan Institute (São Paulo, 
SP, Brazil), i.e., virtually no neutralization of PLA
2
 activity, 
~15–20% neutralization of proteolytic activity and ~70% 
neutralization of hyaluronidase activity, despite the high 
overall immunoreactivity of the venom with this antivenom 
in ELISA. These authors also showed that the SDS-PAGE 
profile of B. fonsecai venom was similar to that of various 
other Bothrops species, with prominent protein bands at 
~14 kDa (corresponding to PLA
2
), 20–26 kDa (probably 
corresponding to class P1 snake venom metalloproteinases 
- SVMPs) and 50–60 kDa (probably corresponding to class 
P3 SMVPs and other proteins). In immunoblotting, com-
mercial bothropic antivenom reacted with these major pro-
tein bands. In addition to these studies, proteomic analyses 
have shown that B. fonsecai venom contains a variety of 
peptides (Tashima et al, 2012) and the major protein/toxin 
classes found in other Bothrops venoms, i.e., PLA
2
, SVMPs, 
serine proteases, C-type lectins, L-amino acid oxidase and 
disintegrins (Tashima et al, 2008). Approximately 30% and 
43% of B. fonsecai venom proteins are PLA
2
 and SVMPs, 
respectively, whereas in B. cotiara, no PLA
2
 were detected 
and SVMPs accounted for 73% of proteins (Tashima et al, 
2008).
In contrast to these biochemical studies, very little is known 
of the biological activities of B. fonsecai venom. The lethal-
ity of this venom in mice (LD
50
 56.8mg/kg, i.p.) is similar to 
that of B. cotiara (53.8mg/kg) and slightly greater than that 
of B. alternatus (63.7mg/kg) and B. itapetiningae (74.4mg/
kg) (Queiroz et al, 2008). Although the high content of 
PLA
2
 and SVMPs indicated by proteomic analysis suggest 
that this venom probably causes myonecrosis and hemor-
rhage mediated by PLA
2
 (Gutiérrez and Ownby, 2003) and 
SVMPs (Escalante et al, 2011), respectively (as in other 
Bothrops venoms), there has been no detailed investigation 
of these activities in this venom. The presence of PLA
2
 also 
suggests that B. fonsecai could adversely affect neurotrans-
mission in vertebrate neuromuscular preparations in vitro, 
particularly since several Bothrops snake venoms have been 
shown to block neurotransmission by a combination of pre- 
and postsynaptic mechanisms, the latter involving muscle 
damage (myotoxicity) (Cogo et al, 1998; Rodrigues-Simioni 
et al, 2004; Zamunér et al, 2004; Durigon et al, 2005; Cogo 
et al, 2006; Cavalcante et al, 2011; Zamunér et al, 2011; 
Moraes et al, 2012). Various studies have shown that venom 
PLA
2
 are the principal components involved in this neuro-
muscular damage (Gallaci and Cavalcante, 2010; Galbiatti 
et al, 2012; Floriano et al, 2013). Based on these consid-
erations, in this work we investigated the neuromuscular 
activity of B. fonsecai venom in chick biventer cervicis and 
mouse phrenic nerve-diaphragm muscle preparations.
MATERIALS AND METHODS
Reagents and venom 
Acetylcholine was obtained from Sigma Chemical Co (St 
Louis, MO, USA). Commercial kits for the measurement 
of creatine kinase (CK) activity were from Laborlab (Capão 
Bonito, SP, Brazil). The salts for physiological solutions 
were from Synth (São Paulo, SP, Brazil) and Merck (Rio de 
Janeiro, RJ, Brazil). Bothrops fonsecai venom was obtained 
from five adult specimens of both sexes captured in the 
Serra da Mantiqueira mountain range in the municipality 
of Campos do Jordão, São Paulo state. The snakes were 
maintained in the Serpentarium of the Centro de Estudos da 
Natureza at the Universidade do Vale do Paraíba (UNIVAP; 
license SMA 15380/2012). The venom was milked manu-
ally, lyophilized and stored at 4oC until used. 
Animals
Male HY-LINE W36 chicks (4–8 days old) were supplied by 
Granja Globo Aves Agrícola Ltda. (Campinas, SP, Brazil) 
and male Swiss white mice (25–30gm) were obtained from 
Anilab S/A (Paulínia, SP, Brazil). The animals were housed 
at 25oC on a 12hrs light/dark cycle and had free access to 
food and water. All procedures were done in accordance 
with the general guidelines of the Brazilian Society of Labo-
ratory Animal Science (SBCAL) and were approved by the 
Committee for Ethics in Animal Use (CEUA/UNIVAP, Pro-
tocol No A102/CEP/2007).
Chick biventer cervicis (CBC) preparations 
Chicks were killed with an overdose of a mixture of xyla-
zine plus ketamine (Syntec, Cotia, SP, Brazil) administered 
i.p. and biventer cervicis (CBC) muscle preparations were 
mounted as described by Ginsborg and Warriner (1960), 
under a resting tension of 1gm in a 4ml organ bath containing 
warmed (37°C), aerated (95%,v/v, O
2
 - 5%,v/v, CO
2
) Krebs 
solution (pH 7.5) of the following composition (mM): NaCl 
118.7, KCl 4.7, CaCl
2
 1.88, KH
2
PO
4
 1.17, MgSO
4
 1.17, 
NaHCO
3
 25.0 and glucose 11.65. Field (i.e., nerve) stimula-
tion was done using bipolar electrodes coupled to a Grass 
S4 stimulator (supramaximal stimuli at 0.1Hz and 0.2ms). 
The preparations were allowed to stabilize for 15–20min 
prior to testing with venom. Venom (in 200ml) was added 
to the organ bath (final concentrations: 40, 80 and 160µg/
ml) and muscle contractions were recorded for up to 120min 
via an isometric transducer (BG-25 GM Kulite) connected 
to a Gemini 7070 recorder (Ugo Basile). The venom con-
centrations used here were chosen based essentially on the 
concentration range (10–200µg/ml) over which other Both-
rops venoms have been shown to be active in CBC and PND 
(see below) preparations (Rodrigues-Simioni et al, 2004; 
Zamunér et al, 2004; Abreu et al, 2007; Moraes et al, 2012). 
The incubation time of 120min, which is sufficient for 
complete blockade by various Bothrops venoms, was like-
wise chosen based on previous studies. Muscle responses 
to exogenous acetylcholine (ACh, 110µM) and potassium 
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chloride (KCl, 40mM) were obtained in the absence of field 
stimulation before and after venom addition. In some exper-
iments, the preparations were stimulated directly (20V) after 
complete neuromuscular blockade induced by incubation 
with d-tubocurarine (dTc, 10µg/ml); a venom concentra-
tion of 160mg/ml was used in these experiments. In control 
experiments, 200µl of Krebs solution alone was added to the 
organ bath and the muscle contractions then recorded for 
up to 120min. The anesthetic used here (xylazine/ketamine) 
did not significantly affect the twitch responses to electri-
cal stimulation or the contractures to exogenous ACh and 
K+ when compared to preparations from chicks anesthetized 
with isoflurane.
In experiments with 40 and 160µg of venom/ml, aliquots 
(200µl) of the bathing solution were obtained before and 
15, 30, 60, 90 and 120min after venom addition for the 
quantification of muscle creatine kinase (CK) release using 
commercial kits and a Bio2000 Analyzer. CK activity in the 
bathing solution was expressed as U/l, in which one unit 
corresponded to the amount of enzyme that produced 1µmol 
of NADH/min under the assay conditions.
In some experiments, the ability of commercial both-
ropic antivenom to neutralize the neuromuscular activity 
of the venom was assessed by preincubating venom with 
antivenom at a venom:antivenom ratio of 5:1 at 37oC for 
30min prior to testing the residual activity in CBC prepara-
tions. The antivenom used was raised in horses immunized 
with a mixture of Bothrops venoms (B. alternatus, B. jara-
raca, B. jararacussu, B. moojeni and B. neuwiedi) (Cardoso 
et al, 2009) and the venom:antivenom ratio was based on 
the manufacturer´s stated neutralizing capacity (1 ml neu-
tralizes 5mg of B. jararaca venom; Butantan Institute, São 
Paulo, SP, Brazil). The venom concentration (200µg/ml) 
and venom:antivenom ratio used in these experiments were 
chosen to allow direct comparison with similar work using 
other Bothrops venoms (Zamunér et al, 2004).
Phrenic nerve-diaphragm muscle (PND) preparation 
Phrenic nerve-diaphragm preparations were obtained from 
mice killed with an overdose of a mixture of xylazine plus 
ketamine (Syntec) administered i.p. The preparations were 
mounted under a tension of 2gm in 5ml tissue baths contain-
ing Tyrode solution (pH 7.4, 37°C) of the following com-
position (mM): NaCl 137, KCl 2.7, CaCl
2
 1.8, MgCl
2
 0.49, 
NaH
2
PO
4
 0.42, NaHCO
3
 11.9 and glucose 11.1, as described 
by Bülbring (1946). The preparations were stimulated indi-
rectly (supramaximal voltage, 0.1Hz, 0.2ms) with stimuli 
delivered from a Grass S4 stimulator. The resulting muscle 
tension was recorded using a force displacement transducer 
(BG 25 GM Kulite) coupled to a Gould RS 3400 recorder. 
The preparations were allowed to stabilize for at least 15min 
before the addition of venom (100 and 200mg/ml). 
Resting membrane potential (RP) and miniature end-
plate potentials (MEPPs) 
The resting membrane potential (recorded at or distant from 
the end-plate region) and miniature end-plate potentials 
(MEPPs) were recorded from mouse diaphragm muscle 
using conventional microelectrode techniques, as described 
by Dal Belo et al (2005). The dissected muscle was mounted 
in a Lucite chamber containing Tyrode solution (pH 7.4) at 
30oC and gassed with 5%,v/v, CO
2
-95%,v/v, O
2
. The RP 
and MEPPs of several fibers in each muscle were recorded 
using glass microelectrodes filled with 3M KCl (resistance 
10–20W) placed inside the muscle fiber. The recordings 
were taken at 0 (basal) and 15, 30, 60, 90 and 120min after 
addition of venom (100 and 200mg/ml). 
Histological analysis 
At the end of the 120min incubation with venom (40, 80 and 
160mg/ml) the CBCs were fixed in Bouin solution contain-
ing 4% formol followed by dehydration in a graded ethanol 
series (70%, 80%, 95% and three times in 100%, 30min 
each) and embedding in paraplast. After polymerization at 
60oC, the tissues were mounted in blocks and sections 5 mm 
thick were cut with a microtome (Leica model RM 2145, 
Leica Microsystems, Heerbrugg, Switzerland). The sections 
were stained with hematoxylin and eosin and examined by 
light microscopy using an Olympus microscope (Olympus 
Optical Co Ltd, Tokyo, Japan) prior to photographing. The 
extent of muscle damage was calculated by expressing the 
number of damaged fibers as a percentage of the total num-
ber of fibers (125) counted per muscle (one microscopic 
field analyzed in each of 10 sections per muscle; four mus-
cles per incubation with saline or venom). 
Statistical analysis 
The contractile responses to electrical stimulation were 
expressed as a percentage of the basal values of each prepa-
ration (taken as 100% prior to the addition of venom or con-
trol Krebs or Tyrode solution). The post-venom responses 
to exogenous ACh and KCl were also expressed as a per-
centage of the responses obtained before the addition of 
venom or control solution. Myonecrosis was expressed 
as the percentage of damaged fibers relative to the total 
number of fibers counted and creatine kinase release was 
expressed in absolute values (U/L). All data (absolute values 
and percentages) were expressed as the mean ±SEM of the 
number of experiments indicated. Statistical comparisons 
were based on the absolute values or percentages and were 
done using Student’s unpaired t-test or by analysis of vari-
ance (ANOVA) followed by the Bonferroni test. A value of 
p<0.05 indicated significance. 
RESULTS
Effects of B. fonsecai venom in CBC neuromuscular 
preparation 
In CBC preparations, venom (40, 80 and 160mg/ml) pro-
duced blockade of indirectly evoked twitches (Figure 1A, 
B). The time required for the venom to cause a 50% reduc-
tion in the contractile responses, i.e., 50% blockade or t
50
, at 
concentrations of 80 and 160mg/ml was 84.9±9.3min and 
73.3±7.6min, respectively (mean±SEM, n=6 each); the low-
est concentration (40mg/ml) produced <50% blockade after 
120min compared to a maximum blockade of 85.6±14% 
with the highest venom concentration. None of the venom 
concentrations tested had any significant effect on the base-
line tension of the preparation, i.e., there was no muscle 
contracture (Figure 1A, traces 2 and 3). However, incubation 
with all venom concentrations attenuated the contractures 
to exogenous ACh and KCl (Figure 1A). The inhibition of 
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contractures to ACh (110mM) was 78.5±9.2%, 88.7±6.8% 
and 100±0% for 40, 80 and 160 mg/ml, respectively (n=4 
each), and that of KCl (40mM)-induced contractures was 
45.2±6.7%, 67.5±2.6% and 89.7±1.5% for 40, 80 and 160 
µg/ml, respectively (n=4 each), compared to pre-venom val-
ues. 
In directly stimulated CBC, venom (160mg/ml; n=4) pro-
duced a progressive reduction in contractile force that 
was not significantly different from that seen in indirectly 
stimulated preparations (Figure 2); the t
50 
in these prepara-
tions was 87.5±8.1min for direct stimulation compared to 
73.3±7.6min for indirect stimulation (n=6 each). 
Effects of B. fonsecai venom in PND neuromuscular 
preparation 
In PND preparations, venom (100 and 200mg/ml) caused 
blockade with t
50
 of 94±13 min and 49±8min, respectively, 
and t
90
 (time to 90% blockade) of 161±8min and 90±15min 
(n=4 each), respectively (Figure 3), indicating that this prep-
aration was less sensitive to venom than CBC preparations 
(see previous section). There were no significant changes in 
the RP or in the amplitude of MEPPs in diaphragm muscle 
incubated with venom (100 and 200mg/ml; n=3 each) for up 
to 120min (data not shown), nor was there any increase in 
baseline tension, i.e., no muscle contracture. 
Muscle damage assessed by CK release and histological 
analysis 
Incubation with venom resulted in a progressive increase in 
CK release during the experiment (Figure 4A) that was sug-
gestive of muscle damage. This damage was confirmed by 
histological analysis, which showed extensive myonecrosis 
that involved delta lesions, as well as the presence of edema-
tous and vacuolated cells (Figure 4B, C). 
Neutralization of the neuromuscular action of venom by 
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Figure 2. Neuromuscular blockade caused by B. fonsecai venom (160µg/ml) in directly and indirectly stimulated CBC preparations. 
There was no difference in the time required for 50% blockade or in the extent of blockade after 120min in each case. The points are 
the mean±SEM (n=6). *p<0.05 compared to control preparations.
Figure 1. Representative recordings (A) and mean responses (B) for the neuromuscular blockade caused by B. fonsecai venom in 
CBC preparations. The preparations were mounted and stimulated as described in the Methods. In A, recording 1 represents a control 
(Krebs solution only) preparation and recordings 2 and 3 represent the responses to B. fonsecai venom (40µg/ml and 160µg/ml, 
respectively). Note the progressive decrease in the contractile responses in the presence of venom, especially with the highest concen-
tration, and the marked attenuation of contractures to exogenous ACh (110µM; black squares) and KCl (40mM; black circles) after 
120min. w – wash. In B, the points are the mean±SEM (n=6). *p<0.05 compared to control preparations. 
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Figure 3. Twitch-tension responses of mouse PND preparations incubated with B. fonsecai venom (100 and 200µg/ml). The points are 
the mean±SEM (n=4). *p<0.05 compared to control preparations.
Preincubation of venom with commercial bothropic 
antivenom at a venom:antivenom ratio of 5:1 resulted in 
complete neutralization of the venom-induced neuromuscu-
lar blockade in CBC preparations (Figure 5). The inhibition 
of contractile responses to ACh and K+ seen with venom 
alone was also completely prevented by antivenom (% con-
tractures at the end of the incubation relative to basal: ACh 
108±13, K+ 104±12).
DISCUSSION
The results of this study show that, in common with other 
Bothrops species (Cogo et al, 1993; Prianti et al, 2003; 
Zamunér et al, 2004; Rodrigues-Simioni et al, 2004; Abreu 
et al, 2007; Cavalcante et al, 2011; Rodrigues-Simioni et al, 
2011), B. fonsecai venom adversely affects neuromuscu-
lar responses in vertebrate nerve-muscle preparations. The 
mechanism responsible for this neuromuscular blockade 
appears to involve essentially extensive damage to the skele-
tal muscle contractile machinery as shown by (1) the marked 
attenuation of the responses to exogenous ACh and KCl, (2) 
the very similar responses to venom in directly and indi-
rectly stimulated preparations and (3) the extensive myone-
crosis confirmed by CK release and histological analysis. 
The potency of B. fonsecai venom in producing neuromus-
cular blockade in CBC was similar to that of several other 
Bothrops venoms (80–200mg/ml) (Zamunér et al, 2004), 
but considerably less than that of Bothrops venoms with a 
known presynaptic action (blockade at <20mg/ml) (Rodri-
gues-Simioni et al, 2004, 2011; Cavalcante et al, 2011), i.e., 
B. fonsecai venom caused only slight/moderate blockade 
(<33%) at a concentration of 40mg/ml. This low potency 
agrees with the suggestion that this venom interferes with 
neuromuscular responses primarily by acting postsynapti-
cally. 
CBC preparations were more sensitive to B. fonsecai venom 
than PND preparations. Greater sensitivity of avian com-
pared to mammalian preparations has also been seen with 
other Bothrops venoms e.g., B. alcatraz (Moraes et al, 2012), 
B. insularis (Cogo et al, 1993), B. marajoensis (Cavalcante 
et al, 2011) and Bothriopsis (Bothrops) bilineata smar-
agdina (Rodrigues-Simioni et al, 2011), whereas in some 
cases the PND is more sensitive, e.g., B. neuwiedi goyazen-
sis (= B. neuwiedi) (Abreu et al, 2007), or both preparations 
may show similar sensitivity, e.g., B. neuwiedi pauloensis (= 
B. pauloensis). Table 1 summarizes the sensitivity of CBC 
and PND to several Bothrops venoms based on the times 
required for 50% and 90% neuromuscular blockade (t
50
 and 
t
90
, respectively). Direct comparison between many of these 
studies is complicated by the fact that the same concentra-
tions have not been systematically used for all venoms in 
each preparation, nor have the same lots of venom been used 
in different studies of the same species. Despite these limita-
tions, the patterns of PND sensitivity noted above (less than, 
similar to or greater than CBC) can be seen. In addition, 
the CBC is particularly sensitive to blockade by venoms 
with marked presynaptic activity that contain presynapti-
cally active PLA
2
, e.g., B. insularis (Cogo et al, 1993; Cogo 
et al, 1998; Cogo et al, 2006), B. pauloensis (=B. neuwiedi 
pauloensis) (Borja-Oliveira et al, 2003, Borja-Oliveira et al, 
2006; Rodrigues-Simioni et al, 2004), B. marajoensis (Cav-
alcante et al, 2011; Galbiatti et al, 2012) and B. b. smarag-
dina (Rodrigues-Simioni et al, 2011; Floriano et al, 2013).
The lower sensitivity of PND to Bothrops venoms compared 
to CBC could reflect anatomical differences in the muscle 
fibers and form of innervation (monofocal in PND and mul-
tifocal in CBC) of the two preparations, with CBC being 
more sensitive to exogenous agents such as ACh and K+ 
(see Cavalcante et al, 2011 and discussion therein). Another 
possibility is that the lower sensitivity of PND may reflect 
a mammalian adaptation to provide resistance to Bothrops 
venoms since mammals are an important part of the diet 
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( Martins et al, 2002). However, closer analysis suggests 
that the relationship between prey type and sensitivity 
to Bothrops venoms is not strictly direct or particularly 
strong, as shown by various exceptions: (1) for B. insula-
ris, a semi-arboreal species that feeds almost exclusively 
on birds (there are no mammals on the Island of Queimada 
Grande off the coast of São Paulo State where this species 
is endemic) (Table 1), the CBC is still more sensitive than 
the PND to this species´ venom, i.e., the logic applied to 
the sensitivity of mammalian prey does not apply here; a 
similar situation occurs with the island species B. alcatraz 
found on the Island of Alcatraz (also off the coast of São 
Paulo State) and that feeds primarily on centipedes (67% of 
diet) and anurans (33% of diet) (Martins et al, 2002) yet has 
a venom that produces blockade in CBC and PND, with the 
latter being less sensitive (Moraes et al, 2012); indeed, at a 
concentration of 10mg/ml, this venom produces blockade in 
CBC with t
50
 and t
90
 (41±4min and 68±8min, respectively) 
similar to those of mainland B. pauloensis [=B. neuwiedi in 
Rodrigues-Simioni et al (2004)] shown in Table 1; (2) the 
sensitivity of CBC and PND to the venom of B. pauloensis, 
a mainland terrestrial species that feeds on mammals (35% 
of diet) but few birds (3% of diet), is similar to that of B. 
insularis that feeds primarily on birds (Table 1. Compari-
son of the times required for B. fonsecai and other Bothrops 
venoms to produce neuromuscular blockade in CBC and 
PND preparations 1; Rodrigues-Simioni et al, 2004), and 
(3) for B. neuwiedi (includes B. n. goyazensis and other sub-
species; Silva, 2004; Silva and Rodrigues, 2008), which has 
an almost totally mammalian diet, the PND is more sensi-
tive than CBC (Abreu et al, 2007) , i.e., the opposite of that 
seen with various other Bothrops venoms. Overall, these 
observations indicate that there is scope for detailed investi-
gation into the relationship between prey type and sensitiv-
ity to Bothrops venoms.
The myonecrosis observed here most likely reflected the 
action of myotoxic PLA
2
 in this venom since these tox-
ins are abundant in Bothrops venoms and are important 
 contributors to this damage (Gutiérrez and Ownby, 2003) 
of many species in this genus (Martins et al, 2002). Table 
1 summarizes the dietary composition for various Bothrops 
species and shows that while for several of these species 
mammals are indeed an important component, only in B. 
fonsecai (and the related B. alternatus and B. cotiara; not 
shown in the Table) is the diet exclusively mammalian 
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Figure 4. Muscle damage caused by B. fonsecai venom in CBC 
preparations. A. Creatine kinase (CK) release during incubation 
with venom (40 and 160µg/ml). CK release in response to an 
intermediate venom concentration (80µg/ml) was not examined 
since the responses to 40 and 160µg/ml were very similar. The 
points are the mean±SEM (n=6). *p<0.05 compared to control 
preparations. B. Morphological alterations in chick BC muscle 
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erally-located nuclei and panels 2–4 show extensive cell dam-
age and myonecrosis. Arrows – myonecrosis, d – delta lesions, 
e – edematous cells, v – vacuolated cells. Transversal sections, 
HE staining. Scale bars in micrometers. C. Quantitative analysis 
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calculated by expressing the number of myonecrotic fibers as a 
percentage of the total number of fibers counted in the muscles of 
each group. The extent of myonecrosis increased with the venom 
concentration. The points are the mean±SEM (n=6). *p<0.05 
compared to the control group (Krebs alone).
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cotiara and B. itapetiningae) with commercial antivenom 
that was similar to those of B. jararaca, B. jararacussu and 
B. moojeni, whereas B. alternatus and B. neuwiedi showed 
lower cross-reactivity (Queiroz et al, 2008). In a study of 
the neuromuscular actions of several Bothrops venons 
(200mg/ml) in CBC and their neutralization by commercial 
antivenom (at a venom:antivenom ratio of 5:1), Zamunér et 
al (2004) noted that only the venom of B. moojeni was com-
pletely neutralized in a manner similar to that seen here for 
B. fonsecai; the other venoms (B. erythromelas, B. jararaca, 
B. jararacussu and B. neuwiedi) showed variable neutraliza-
tion, even though the latter three were part of the immuniza-
tion pool. Similarly, Queiroz et al (2008) noted that despite 
the high ELISA cross-reactivity of B. fonsecai venom with 
antivenom there was considerable variation in the neutral-
izing capacity towards selected enzymatic activities, e.g., 
virtually no neutralization of PLA
2
 activity, ~15–20% neu-
tralization of proteolytic activity and ~70% neutralization 
of hyaluronidase activity. The lack of neutralization of PLA
2
 
activity is interesting in view of the suggestion made above 
that PLA
2
 may be involved in the venom-induced neuro-
muscular alterations and the finding that antivenom com-
pletely neutralized the neuromuscular effects of the venom. 
This discrepancy may be explained by the fact that whereas 
PLA
2
 activity assays depend on catalytically active enzymes, 
many of the PLA
2
 that exert marked neuromuscular effects 
are basic PLA
2
 with very low or no enzymatic activity (cata-
lytically inactive) (Gallacci and Cavalcante, 2010).
The finding that B. fonsecai venom contains the major pro-
tein/toxin classes present in other Bothrops venoms (Queiroz 
et al, 2008; Tashima et al, 2008; Tashima et al, 2012) sug-
gests that bites by this species will probably result in local 
(edema, pain, inflammation, hemorrhage and necrosis) and 
systemic (coagulopathy, internal bleeding, hypotension, cir-
culatory shock and renal failure) manifestations similar to 
the general pattern observed for other venoms of this genus 
(Warrell, 2004; França and Málaque, 2009). However, there 
are no detailed literature reports of envenoming by Bothrops 
spp. in which B. fonsecai has been conclusively identified as 
the offending species; this situation partly reflects the remote, 
sparsely populated (by humans) regions where this species 
occurs. Whilst bites by this species probably have occurred, 
the general lack of identification of the offending snake to 
the species level at the attending clinics or hospitals and the 
probably similar manifestations to those of other Bothrops 
spp. means that most bites by this species have generally 
gone unnoticed and been (wrongly) attributed to more com-
mon Bothrops species, e.g., B. alternatus, B. jararaca and/or 
B. jararacussu that are responsible for most cases of Both-
rops envenoming in southeastern Brazil. This lack of infor-
mation makes it difficult to precisely assess the relevance of 
the present findings to envenoming by this species.
CONCLUSIONS
The results of this study show that B. fonsecai venom can 
adversely affect muscle contraction in vertebrate neuromus-
cular preparations, essentially by interference with nicotinic 
receptor functioning and direct damage to the muscle. This 
profile of activity is similar to that reported for B. alcatraz 
and to neuromuscular blockade (Gallaci and Cavalcante, 
2010). Muscle damage induced by myotoxic PLA
2
 involves 
a series of intracellular responses triggered by membrane 
permeabilization (via membrane phospholipid degradation 
in the case of catalytically active PLA
2
 or membrane per-
turbation in the case of catalytically inactive PLA
2
) and the 
subsequent entry of extracellular calcium that can lead to 
muscle contracture, activation of intracellular proteolytic 
pathways and mitochondrial damage (Montecucco et al, 
2008). As shown here, in neither of the preparations used did 
B. fonsecai venom cause muscle contracture (an increase in 
baseline tension generally associated with extensive uncon-
trolled entry of extracellular Ca2+) nor were there significant 
changes in the membrane resting potential in mouse dia-
phragm muscle. Nevertheless, the attenuated responses to 
exogenous K+, the release of CK and the histological find-
ings indicated the occurrence of muscle damage. Although 
no myotoxic PLA
2
 have yet been characterized from B. 
fonsecai venom, this venom does contain PLA
2
 activity 
(Queiroz et al, 2008) and SDS-PAGE and 2D electropho-
retic analyses have demonstrated the presence of PLA
2
 in 
this venom (Queiroz et al, 2008; Tashima et al, 2008). These 
PLA
2
 could be responsible for the neuromuscular actions 
of the venom. In relation to this, it is worth noting that the 
venom of the taxonomically related B. alternatus contains a 
basic PLA
2
 that is active at vertebrate neuromuscular junc-
tions (Ponce-Soto et al, 2007; Ponce-Soto et al, 2009). 
Metalloproteinases, which are abundant in Bothrops ven-
oms (Escalante et al, 2011) and present in B. fonsecai venom 
(Tashima et al, 2008), could also theoretically contribute to the 
muscle damage observed here, perhaps by cleaving surface 
proteins important for the postsynaptic interaction of PLA
2
 
with skeletal muscle membrane and/or the binding of ACh to 
postsynaptic nicotinic receptors, as suggested for the venoms 
of B. alcatraz (Moraes et al, 2012) and B.  leucurus (Prianti 
et al, 2003). In this regard, a proteolytic fraction from Both-
rops lanceolatus venom has been shown to produce contrac-
ture and irreversible neuromuscular blockade in CBC, with 
a decrease in the responses to exogenous ACh but no effect 
on the contracture to K+; the fraction produced membrane 
 depolarization but had no presynaptic effect on miniature end-
plate potential (MEPP) frequency or amplitude, i.e., the effect 
was solely postsynaptic (Lôbo de Araújo et al, 2002).
Preincubation of venom with commercial antivenom at the 
venom:antivenom ratio recommended by the manufacturer 
completely prevented the venom-induced decrease in the 
contractile responses to electrical stimulation and restored 
the contractures to exogenous ACh and K+. This finding 
indicated that although B. fonsecai venom was not included 
in the venom pool used in the immunization protocols dur-
ing antiserum production, there was apparently sufficient 
cross-reactivity among these venoms to ensure good neu-
tralization of this activity. This cross-reactivity may be 
explained not only by the presence of shared antigenically-
related proteins among these venoms but also by the fact 
that the venom pool used in immunization contained venom 
from B. alternatus, a species taxonomically closely related 
to B. fonsecai (Salomão et al, 1977; Salomão et al, 1999; 
Wüster et al, 2002). The neutralization of the neuromuscu-
lar actions of B. fonsecai venom seen here agreed with the 
high ELISA cross-reactivity of this venom (and those of B. 
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